Form D · Biotechnology
Xanadu Bio, Inc.
Gladwyne, PA · CIK 0001946059
Offering snapshot reported Aug 27, 2025 · SEC filing
- Reported sold
- $11M Offering amount: $11M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2025 | Initial | $10,999,994 | No comparison | 4 | SEC filing |
| Dec 27, 2022 | Initial | $11,999,986 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-555995
Source: Form D, filed Aug 27, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Taylor Feehley | Executive |
| Mark Saltzman | Director |
| Bruce Turner | Director, Executive, Promoter |
| Todd Wider | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
980 Idlewild Road
Gladwyne, PA, 19035
Gladwyne, PA, 19035